The human natural killer lymphocyte receptors for MHC class I molecules

European Cytokine Network

Volumn 9, Issue 4, 1998, Pages 577-583

  Bensussan, Armand ^a  

^a FACULTÉ DE MÉDECINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; CYTOKINE; IMMUNOGLOBULIN G; LYMPHOCYTE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ALLELE; CYTOKINE PRODUCTION; CYTOTOXICITY; HUMAN; IMMUNE RESPONSE; MOLECULAR CLONING; NATURAL KILLER CELL; REVIEW;

ANTIBODIES, MONOCLONAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LECTINS; RECEPTORS, IMMUNOLOGIC;

EID: 0032411003     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Herberman R B, Nunn M E, Lavrin D H. 1975. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. I. Distribution of reactivity and specificity. Int. J. Cancer 16: 216.
2. Kiessling R, Klein E, Wigzell H. 1975. "Natural Killer" cells in mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol. 5: 112.
3. Bancroft G J. 1993. The role of natural killer cells in innate resistance to infection. (Review) Curr. Opin. Immunol. 5: 503.
4. Scott P, Trinchieri G. 1995. The role of natural killer cells in host-parasite interactions. (Review) Curr. Opin. Immunol. 7: 34.
5. Bancroft G J, Schreiber R D, Bosma G C, Bosma M J, Unanue E R. 1987. A T cell-independent mechanism of macrophage activation by interferon-γ. J. Immunol. 139: 1104.
6. Chen L K, Tourvieille B, Burns G F, Bach F H, Mathieu-Mahul D, Sasportes M, Bensussan A. 1986. Interferon: a cytotoxic T lymphocyte differentiation signal. Eur. J. Immunol. 16: 767.
7. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178: 567.
8. Lanier L L, Le A M, Phillips J H, Warner N L, Babcock G F. 1983. Subpopulations of human natural killer cells defined by expression of Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J. Immunol. 131: 1789.
9. Perussia B, Starr S, Abraham S, Fanning V, Trinchieri G. 1983. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. J. Immunol. 130: 2133.
10. A and NKH2, expressed on subsets of large granular lympocytes. J. Clin. Invest. 75: 932.
11. Lanier L L, Le A M, Civin C I, Loken M R, Phillips J H. 1986. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J. Immunol. 136: 4480.
12. Voss S D, Daley J, Ritz J, Robertson M J. 1998. Participation of the CD94 receptor complex in costimulation of human natural killer cells. J. Immunol. 160: 247.
13. Warren H S, Kinnear B F, Kastelein R L, Lanier L L. 1996. Analysis of the costimulatory role of IL-2 and IL-15 in initiating proliferation of resting (CD56dim) human NK cells. J. Immunol. 156: 3254.
14. Lanier L L, Ruitenberg J J, Phillips J H. 1988. Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes. J. Immunol. 141: 3478.
15. Anegon I, Cuturi M C, Trincheri G, Perussia B. 1988. Interaction of Fc receptor (CD16) ligands induces transcription of interleukin-2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells. J. Exp. Med. 167: 452.
16. Cuturi M C, Anegon I, Sherman F, Loudon R, Clark S C, Perussia B, Trinchieri G. 1989. Production of hemalopoietic colony-stimulating factors by human natural killer cells. J. Exp. Med. 169: 569.
17. Lanier L L, Yu G, Phillips J H. 1989. Co-association of CD3ζ with a receptor (CD16) for IgG Fc on human natural killer cells. Nature 342: 803.
18. Vivier E, Morin P, O'Brien C, Druker B, Schlossman S F, Anderson P. 1991. Tyrosine phosphorylation on the FcγRIII (CD16): ζ complex in human natural killer cells. Induction by antibody dependent cytotoxicity but not by natural killing. J. Immunol. 146: 206.
19. Viver E, da Silva A J, Ackerly M, Levine H, Rudd C E, Anderson P. 1993. Association of a 70-kDa tyrosine phosphoprotein with CD16: ζ;γ complex expressed in human natural killer cells. Eur. J. Immunol. 23: 1872.
20. Thomas M L. 1995. Of ITAMs and ITIMs: turning on and off the B cell antigen receptor. (Review) J. Exp. Med. 181: 1953.
21. Lanier L L. 1997. Natural killer cells, from no receptors to too many. (Review) Immunity 6: 371.
22. Burshtyn D N, Scharenberg A M, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet J P, Long E O. 1996. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor. Immunity 4: 77.
23. Fry A M, Lanier L L, Weiss A. 1996. Phosphotyrosines in the killer cell inhibitory receptor motif of NKB1 are required for negative signaling and for association with protein tyrosine phosphatase 1C. J. Exp. Med. 184: 295.
24. Campbell K S, Dessing M, Lopez-Botet M, Cella M, Colonna M. 1996. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J. Exp. Med. 184: 93.
25. Olcese L, Lang P, Vely F, Cambiaggi A, Marguer D, Blery M, Hippen K L, Biassoni R, Moretta A, Moretta L, Cambier J C, Vivier E. 1996. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. J. Immunol. 156: 4531.
26. Samaridis J, Colonna M. 1996. Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: structural evidence for new stimulatory and inhibitory pathways. Eur. J. Immunol. 27: 660.
27. Cosman D, Fanger L, Borges L, Kubin M, Chin W, Peterson L, Hsu M L. 1997. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7: 273.
28. Colonna M, Navarro F, Bellon T, Llano M, Garcia P, Sumaridis J, Angman L, Cella M, Lopez-Botet M. 1997. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186: 1809.
29. Colonna M, Samaridis J, Cella M, Angman L, Allen R L, O'Callaghan C A, Dunbar R, Ogg G S, Cerundolo V, Rolink A. 1998. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J. Immunol. 160: 3096.
30. Bensussan A, Mansur I G, Mallet V, Rodriguez A M, Girr M, Weiss E H, Brem G, Boumsell L, Gluckman E, Daussel J, Carosella E, Le Bouteiller P. 1995. Detection of membrane-bound HLA-G translated products with a specific monoclonal antibody. Prof. Natl. Acad. Sci. USA 92: 10292.
31. + natural killer cells. Role in cell activation and regulation of cytolytic function. J. Exp. Med. 171: 695.
32. + natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition. J. Exp. Med. 172: 1589.
33. Ciccone E, Pende D, Viale O, Di Donato C, Orengo A M, Biussoni R, Verdiani S, Amoroso A, Moretta A, Moretta L. 1992. Involvement of HLA class I alleles in natural killer (NK) cell specific function: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). J. Exp. Med. 176: 963.
34. Moretta A, Vitale M, Bottino C, Orengo A M, Morelli L, Augugliaro R, Barbaresi M, Ciccone E, Moretta L. 1993. p58 molecules as putative receptor for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 178: 597.
35. Biassoni R, Falco M, Cambiaggi A, Costa P, Verdiani S, Pende D, Conte R, Di Donato C, Parham P, Moretta L. 1995. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J. Exp. Med. 182: 605.
36. Colonna M, Brooks E G, Falco M, Ferrara G B, Strominger J L. 1993. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. Science 260: 1121.
37. Ciccone E, Pende D, Vitale M, Nanni L, Di Donato C, Bottino C, Morelli L, Viale O, Amoroso A, Moretta A, Moretta L. 1994. Self class I molecules protect normal cells from lysis mediated by autologous natural killer cells. Eur. J. Immunol. 24: 1003.
38. Wagtmann N, Biassoni R, Cantoni C, Verdiani S, Malnati M S, Vitale M, Bottino C, Moretta L, Moretta A, Long E O. 1995. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both extra- and intracellular domains. Immunity 2: 439.
39. Maliszewski C R, March C J, Schoenborn M A, Gimpel S, Shen L. 1990. Expression cloning of a human Fc receptor for IgA. J. Exp. Med. 172: 1665.
40. Arm J P, Gurish M F, Reynolds D S, Scott H C, Gartner C S, Austen K F, Katz H R. 1991. Molecular cloning of gp49, a cell-surface antigen that is preferentially expressed by mouse mast cell progenitors and is a new member of the immunoglobulin superfamily. J. Bol. Chem. 266: 15966.
41. Rajagopalan S, Winter C C, Wagtmann N, Long E O. 1995. The Ig-related killer cell inhibitory receptors binds zinc and requires zinc for recognition of HLA-C on target cells. J. Immunol. 155: 4143.
42. Rajagopalan S, Long E O. 1998. Zinc bound to the killer cell-inhibitory receptor modulates the negative signal in human NK cells. J. Immunol. 161: 1299.
43. D'Ambrosio D, Hippen K L, Minskoff S A, Mellman I, Pani G, Siminovitch K A, Cambier J C. 1995. Recruitment and activation of PTPIC in negative regulation of antigen receptor signaling by Fc gamma RIIB1. Science 268: 293.
44. Doody G M, Justement L B, Delibrias C C, Matthews R J, Lin J, Thomas M L, Fearon D T. 1995. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 269: 242.
45. Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L. 1995. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 182: 875.
46. Lanier L L, Corliss B C, Wu J, Leong C, Phillips J H. 1998. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391: 703.
47. Litwin V, Gumperz J F, Parham P, Phillips J H, Lanier L L. 1994. NKB1: an NK cell receptor involved in the recognition of polymorphic HLA-B molecules. J. Exp. Med. 180: 537.
48. Gumperz J E, Litwin V, Phillips J H, Lanier L L, Parham P. 1995. The Bw4 public epitope of HLA-B molecules confers reactivity with NK cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181: 1133.
49. Lanier L L, Grumperz J E, Parham P, Melero I, Lopez-Botet M, Phillips J H. 1995. The NKB1 and HP-3E4 NK cell receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J. Immunol. 154: 3320.
50. D'Andrea A, Chang C. Franz-Bacon K, McClanahan T, Phillips J H, Lanier L L. 1995. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. J. Immunol. 155: 2306.
51. Pende D, Biassoni R, Cantoni C, Verdiani S, Falco M, di Donato C, Accame L, Bottino C, Moretta A, Moretta L. 1996. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140 kD disulphide-linked dimer. J. Exp. Med. 184: 505.
52. Uhrberg M, Valiante N M, Shum B P, Shilling H G, Lienert-Weidenbach K, Corliss B, Tyan D, Lanier L L, Parham P. 1997. Human diversity in killer cell inhibitory receptor genes. Immunity 1: 753.
53. Valiante N M, Uhrberg M, Shilling H G, Lienert-Weidenbach K, Arnett K L, D'Andrea A, Phillips J H, Lanier L L, Parham P. 1997. Functionally and structurally distinct NK cell receptoires in the peripheral blood of two human donors. Immunity 7: 739.
54. Maiza H, Leca G, Mansur I G, Schiavon V, Boumsell L, Bensussan A. 1993. A novel 80-kD cell surface structure identifies human circulating lymphocytes with natural killer activity. J. Exp. Med. 178: 1121.
55. Bensussan A, Gluckman E, el Marsafy S, Schiavon V, Mansur I G, Dausset J, Boumsell L, Carosella E D. 1994. BY55 monoclonal antibody delineates within human cord blood and bone marrow lymphocytes distinct cell subsets mediating cytotoxic activity. Proc. Natl. Acad. Sci. USA 91: 9136.
56. Anumanthan A, Bensussan A, Boumsell L, Christ A D, Blumberg R S, Voss S D, Patel A T, Robertson M J, Nadler L M, Freeman G J. 1998. Cloning of BY55, a novel Ig superfamily member expressed on NK cells, cytolytic T lymphocytes, and intestinal intraepithelial lymphocytes. J. Immunol. 161: 2780.
57. Lopez-Cabrera M, Santis A G, Fernandez-Ruiz E, Blacher, Esch F, Sanchez-Mateos P, Sanchez-Madrid F. 1993. Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69. a new member of the C-type animal lectin superfamily of signal-transmitting receptors. J. Exp. Med. 178: 537.
58. Lanier L L, Chang C, Phillips J H. 1994. Human NKR-P1A. A disulfide-linked homodimer of the C-type lectin superfamily expressed by a subset of NK and T lymphocytes. J. Immunol. 153: 2417.
59. + T lymphocytes. I. Inhibition of the IL-2 dependent proliferation by anti-Kp43 monoclonal antibody. J. Immunol. 144: 3238.
60. + T lymphocytes. II. Modulation of natural killer cytotoxicity by anti-Kp43 monoclonal antibody. J. Immunol. 147: 714.
61. Houchins J P, Yabe T, McSherry C, Miyokawa N, Bach F H. 1990. Isolation and characterization of NK cell or NK/T cell specific cDNA clones. J. Mol. Cell. Immunol. 4: 295.
62. Houchins J P, Yabe T, McSherry C, Bach F H. 1991. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells. J. Exp. Med. 173: 1017.
63. Yabe T, McSherry C, Bach F H, Fish P, Schall R P, Sondell P M, Houchins J P. 1993. A multigene family on human chromosome 12 encodes natural killer-cell lectins. Immunogenetics 37: 455.
64. Phillips J H, Chang C, Mattson J, Gumperz J, Parham P, Lanier L L. 1996. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A. HLA-B, and HLA-C allotypes. Immunity 5: 163.
65. Brooks A G, Posch P E, Scorzelli C J, Borrego F, Coligan J E. 1997. NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor. J. Exp. Med. 185: 795.
66. Carretero M, Cantoni C, Bellon T, Bottino C, Biassoni R, Rodriguez A, Perez-Villar J J, Moretta L, Moretta A. Lopez-Botet M. 1997. The CD94 and NKG2-A C type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules. Eur. J. Immunol. 27: 563.
67. Cantoni C, Biassoni R, Pende D, Sivori S, Accame L, Pareti L, Semenzato G, Moretta L, Moretta A, Bottino C. 1998. The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene. Eur. J. Immunol. 28: 327.
68. Braud V M, Allan D S, O'Callaghan C A, Söderstrom K, d'Andrea A, Ogg G S, Lazetic S, Young N T, Bell J I, Phillips J H, Lanier L L, McMichael A J. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B. and C. Nature 391: 795.
69. Llano L N, Carretero M, Ishitani A, Navarro F, Lopez-Botet M. Geraghty D E. 1998. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 95: 5199.
70. Mingari M C, Vitale C, Cantoni C, Bellomo R, Ponte M, Schiavetti F, Bertone S, Moretta A, Moretta L. 1997. Interleukin-15-induced maturation of human natural killer cells from early thymic precursor: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur. J. Immunol. 27: 1374.
71. + T cells. Proc. Natl. Acad. Sci. USA 95: 1172.
72. Sivori S, Vitale M, Morelli L, Sanseverino L, Augugliaro R, Bottino C, Moretta L, Moretta A. 1997. p46, a novel natural killer cell-specific surface molecule which mediates cell activation. J. Exp. Med. 186: 1129.
73. Cantoni C, Verdiani S, Falco M, Pessino A, Cilli M, Conte R, Pende D, Ponte M, Mikaelsson M S, Moretta L, Biassoni R. 1998. p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur. J. Immunol. 28: 1980.